Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 24 min ago
Peer-reviewedCC BY-NC-NDInternal Medicine

Embolic Ischemic Stroke Associated with Maintenance Intravenous Immunoglobulin Therapy

Abstract

We describe the case of a 51-year-old man who experienced an embolic ischemic stroke during long-term maintenance of intravenous immunoglobulin (IVIG) therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). At 43 years of age, he was diagnosed with CIDP and had tolerated IVIG well. Immediately after completing the 112th infusion, he exhibited acute right-hand clumsiness. Brain magnetic resonance imaging revealed an acute embolic infarction, and neither risk factors for ischemic stroke nor alternative embolic sources were identified. Although IVIG is generally considered safe, this case highlights that embolic stroke may occur even in relatively younger, low-risk patients during uneventful maintenance IVIG therapy, warranting continued vigilance.

Related

  1. A cumulative biochemical profile of low uric acid and high total bilirubin is associated with hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke: a retrospective cohort study
    Huan Liang, Baiyu Zeng, Jingquan Wang +5
    Frontiers in medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCEurope PMCPMC
  2. Intracranial hemorrhage in a patient with Guillain–Barré syndrome following intravenous immunoglobulin therapy: A rare complication
    Preeti Singh Dhoat, Amandeep Kaur, Rohit Raina +2
    Journal of family medicine and primary carePeer-reviewedCC BY-NC-NDFull textNeurologyEurope PMCPMC
  3. IgM- and IgA-Enriched Polyclonal Intravenous Immunoglobulin Therapy in Sepsis: A Single-Center Retrospective Cohort Study
    Hakan Yılmaz, Melek Tulunay, Ali Abbas Yılmaz
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  4. Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Japanese Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy: A Phase 3, Open-label Clinical Trial
    Satoshi Kuwabara, Kazumoto Shibuya, Yuji Tomizawa +9
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textNeurologyJ-STAGE
  5. Extending the Treatment Window for Intravenous Thrombolysis in Acute Ischemic Stroke
    Soheil Rahmati, Mohammadreza Alinejadfard, Yasaman Zarinfar +9
    Neurology: Clinical PracticePeer-reviewedLicence not statedFull text1 citedEpidemiology & public healthPMC
BibTeX
@article{miyano2026embolic,
  title = {{Embolic Ischemic Stroke Associated with Maintenance Intravenous Immunoglobulin Therapy}},
  author = {Ryoji Miyano and Yu Yoshida and Kazuki Fujita and Yuka Hayashi and Yoshio Sakiyama},
  journal = {Internal Medicine},
  year = {2026},
  month = oct,
  doi = {10.2169/internalmedicine.6976-25},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/20/65_6976-25/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Embolic Ischemic Stroke Associated with Maintenance Intravenous Immunoglobulin Therapy
AU  - Ryoji Miyano
AU  - Yu Yoshida
AU  - Kazuki Fujita
AU  - Yuka Hayashi
AU  - Yoshio Sakiyama
PY  - 2026
DA  - 2026/10/15
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.6976-25
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/65/20/65_6976-25/_article
AB  - We describe the case of a 51-year-old man who experienced an embolic ischemic stroke during long-term maintenance of intravenous immunoglobulin (IVIG) therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). At 43 years of age, he was diagnosed with CIDP and had tolerated IVIG well. Immediately after completing the 112th infusion, he exhibited acute right-hand clumsiness. Brain magnetic resonance imaging revealed an acute embolic infarction, and neither risk factors for ischemic stroke nor alternative embolic sources were identified. Although IVIG is generally considered safe, this case highlights that embolic stroke may occur even in relatively younger, low-risk patients during uneventful maintenance IVIG therapy, warranting continued vigilance.
SN  - 1349-7235
SN  - 0918-2918
ER  -